10x Genomics (TXG) Stock: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$88.76
-1.60 (-1.77%)
▼
5d:
+5.53%
30d:
+47.98%
90d:
+127.53%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $88.76, which is considered extended relative to its 30-day fair value range of $62.72 to $82.33. From a valuation perspective, the stock is trading at a premium (Forward PE: 1157.2) compared to its historical average (185.8). At these levels, the market is pricing in 84.0% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $74.60, while resistance sits at $95.16.
Market Sentiment: TXG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $62.13. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $74.60, while resistance sits at $95.16.
Market Sentiment: TXG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $62.13. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$62.72 -
$82.33
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
9.5%
Protect Your Profits
TXG is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 30.0% above Wall St target ($62.13)
- BEARISH: Market expects 84.0% growth - appears too optimistic based on history
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$62.72 -
$82.33
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$74.60
Resistance Level
$95.16
Current Trend
Strong Uptrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1157.24
Wall Street Target
$62.13
(-30.0%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+84.0% premium
PE vs Historical
1157.2 vs 185.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+84.0%
(market-implied from PE analysis)
1-Year Target
$133.14
(+50%)
2-Year Target
$199.71
(+125%)
3-Year Target
$299.56
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1157→186)
PE COMPRESSION
$48.10
(-46%)
Significant PE compression expected
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 1157.2, Growth: 109.0%)
$299.56
(+238%)
Base:
(SPY PE: 20.4, Growth: 109.0%)
$5.28
(-94%)
Bear:
(PE: 17.3, Growth: 109.0%)
$4.49
(-95%)
Share & Embed Analysis
Last updated: October 01, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$369 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 44 HOLD |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
